Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: Association with cigarette smoking and HLA-DRB1 'shared epitope' alleles

Annals of the Rheumatic Diseases

Volumn 74, Issue 3, 2015, Pages 579-586

  Wagner, Catriona A ^a,b   Sokolove, Jeremy ^a,b   Lahey, Lauren J ^a,b   Bengtsson, Camilla ^c   Saevarsdottir, Saedis ^c   Alfredsson, Lars ^c   Delanoy, Michelle ^d   Lindstrom, Tamsin M ^a,b   Walker, Roger P ^d   Bromberg, Reuven ^a,b   Chandra, Piyanka E ^a,b   Binder, Steven R ^d   Klareskog, Lars ^c   Robinson, William H ^a,b  

^a GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d BIO RAD LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; APOLIPOPROTEIN E; AUTOANTIBODY; BIGLYCAN; BIOLOGICAL MARKER; CITRULLINATED ANTIGEN; CLUSTERIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; EPITOPE; FILAGGRIN; HISTONE H2A; HISTONE H2B; HLA DRB1 ANTIGEN; RHEUMATOID FACTOR; SHARED EPITOPE; UNCLASSIFIED DRUG; VIMENTIN; AUTOANTIGEN; CITRULLINE; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; PEPTIDE;

ADULT; AGED; ALLELE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; INTERMETHOD COMPARISON; MALE; MEDICAL HISTORY; MULTIPLEX BEAD BASED ANTIGEN ARRAY; REPRODUCIBILITY; RHEUMATOID ARTHRITIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING; SYNOVIUM; ADOLESCENT; CASE CONTROL STUDY; GENETICS; GOUT; IMMUNOLOGY; MIDDLE AGED; PSORIATIC ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALLELES; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; CASE-CONTROL STUDIES; CITRULLINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; GOUT; HLA-DRB1 CHAINS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PEPTIDES; PEPTIDES, CYCLIC; SMOKING; YOUNG ADULT;

EID: 84922347461     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203915     Document Type: Article

References (27)

1. Schellekens GA, Visser H, de Jong BA, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000;43:155-63.
2. Van Wenrooij WJ, van Beers JJ, Pruijn GJ. Anti-CCP antibodies: the past, the present and the future. Nat Rev Rheumatol 2011;7:391-8.
3. Hueber W, Kidd BA, Tomooka BH, et al. Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum 2005;52:2645-55.
4. Hueber W, Tomooka BH, Zhao X, et al. Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines. Ann Rheum Dis 2007;66:712-19.
5. Heliövaara M, Aho K, Aromaa A, et al. Smoking and risk of rheumatoid arthritis. J Rheumatol 1993;20:1830-5.
6. Stolt P, Bengtsson C, Nordmark B, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003;62:835-41.
7. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
8. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006;54:38-46.
9. Monach PA, Hueber W, Kessler B, et al. A broad screen for targets of immune complexes decorating arthritic joints highlights deposition of nucleosomes in rheumatoid arthritis. Proc Natl Acad Sci USA 2009;106:15867-72.
10. Zhao X, Okeke NL, Sharpe O, et al. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res Ther 2008;10:R94.
11. Mahdi H, Fisher BA, Källberg H, et al. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet 2009;41:1319-24.
12. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
13. Tibshirani R, Hastie T, Narasimhan B, et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 2002;99:6567-72.
14. Eisen MB, Spellman PT, Brown PO, et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863-8.
15. Bizzaro N, Mazzanti G, Tonutti E, et al. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 2001;47:1089-93.
16. Stone R, Coppock JS, Dawes PT, et al. Clinical value of ELISA assays for IgM and IgG rheumatoid factors. J Clin Pathol 1987;40:107-11.
17. Sebbag M, Moinard N, Auger I, et al. Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur J Immunol 2006;36:2250-63.
18. Lutteri L, Malaise M, Chapelle JP. Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis. Clin Chim Acta 2007;386:76-81.
19. Bizzaro N, Tonutti E, Tozzoli R, et al. Analytical and diagnostic characteristics of 11 2nd- and 3rd-generation immunoenzymatic methods for the detection of antibodies to citrullinated proteins. Clin Chem 2007;53:1527-33.
20. Sghiri R, Bouajina E, Bargaoui D, et al. Value of anti-mutated citrullinated vimentin antibodies diagnosing rheumatoid arthritis. Rheumatol Int 2008;29:59-62.
21. Whiting PF, Smidt N, Steme JA, et al. Systematic review: accuracy of anti-citrullinated peptide antibodies for diagnosing rheumatoid arthritis. Ann Intern Med 2010;152:456-64.
22. Sokolove J, Bromberg R, Deane KD, et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS ONE 2012;7: e35296.
23. Nielen MM, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004;50:380-6.
24. del Val del Amo N, Ibanez BR, Fito MC, et al. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness. Clin Exp Rheumatol 2006;24:281-6.
25. Rönnelid J, Wick MC, Lampa J, et al. Longitudinal analysis of citrullinated protein/ peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 2005;64:1744-9.
26. Vencovský J, Machácek S, Sedová L, et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 2003;62:427-30.
27. van Dongen H, van Aken J, Lard LR, et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2007;56:1424-32.